Header Logo

Anil Chandraker MD

TitleProfessor
InstitutionUMass Chan Medical School
DepartmentMedicine
AddressUniversity of Massachusetts Medical School
55 Lake Ave North
Worcester MA 01605
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentMedicine
    DivisionNephrology


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Schreiber B, Tripathi S, Nikiforow S, Chandraker A. Adoptive Immune Effector Cell Therapies in Cancer and Solid Organ Transplantation: A Review. Semin Nephrol. 2024 Mar 29; 151498. PMID: 38555223.
      Citations:    
    2. Chandraker A, Regmi A, Gohh R, Sharma A, Woodle ES, Ansari MJ, Nair V, Chen LX, Alhamad T, Norman S, Cibrik D, Singh M, Alper A, Jain D, Zaky Z, Knechtle S, Sharfuddin A, Gupta G, Lonze BE, Young JH, Adey D, Faravardeh A, Dadhania DM, Rossi AP, Florescu D, Cardarelli F, Ma J, Gilmore S, Vasileiou S, T Jindra P, Wojciechowski D. Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Am Soc Nephrol. 2024 Mar 12. PMID: 38470444.
      Citations:    
    3. Hanna GJ, Dharanesswaran H, Giobbie-Hurder A, Harran JJ, Liao Z, Pai L, Tchekmedyian V, Ruiz ES, Waldman AH, Schmults CD, Riella LV, Lizotte P, Paweletz CP, Chandraker AK, Murakami N, Silk AW. Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma. J Clin Oncol. 2024 Mar 20; 42(9):1021-1030. PMID: 38252908.
      Citations:    Fields:    
    4. Huck DM, Weber B, Schreiber B, Pandav J, Parks S, Hainer J, Brown JM, Divakaran S, Blankstein R, Dorbala S, Trinquart L, Chandraker A, Di Carli MF. Comparative Effectiveness of PET and SPECT MPI for Predicting Cardiovascular Events After Kidney Transplant. Circ Cardiovasc Imaging. 2024 01; 17(1):e015858. PMID: 38227694.
      Citations:    Fields:    Translation:Humans
    5. Raina R, Jothi S, Haffner D, Somers M, Filler G, Vasistha P, Chakraborty R, Shapiro R, Randhawa PS, Parekh R, Licht C, Bunchman T, Sethi S, Mangat G, Zaritsky J, Schaefer F, Warady B, Bartosh S, McCulloch M, Alhasan K, Swiatecka-Urban A, Smoyer WE, Chandraker A, Yap HK, Jha V, Bagga A, Radhakrishnan J. Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements. Kidney Int. 2024 Mar; 105(3):450-463. PMID: 38142038.
      Citations:    Fields:    
    6. Huck DM, Buckley LF, Chandraker A, Blankstein R, Weber B. Targeting pharmacotherapies for inflammatory and cardiorenal endpoints in kidney disease. J Cardiovasc Pharmacol. 2023 Sep 05. PMID: 37678318.
      Citations: 1     Fields:    
    7. Ueno T, Ikeda T, Okihara M, Akashi I, Yokoyama T, Kihara Y, Konno O, Nakamura Y, Iwamoto H, Ueno Y, Chandraker A. Cytokine modulation in abdominal septic shock via the crucial role of IL-6 signaling in endothelial dysfunction. Front Med (Lausanne). 2023; 10:1042487. PMID: 37007795.
      Citations:    
    8. Heo S, Park Y, Lee N, Kim Y, Kim YN, Shin HS, Jung Y, Rim H, Rennke HG, Chandraker A. Lack of Efficacy and Safety of Eculizumab for Treatment of Antibody-Mediated Rejection Following Renal Transplantation. Transplant Proc. 2022 Oct; 54(8):2117-2124. PMID: 36192209.
      Citations: 1     Fields:    Translation:Humans
    9. Tripathi S, Martin-Moreno PL, Kavalam G, Schreiber BL, Waaga-Gasser AM, Chandraker A. Adenosinergic Pathway and Linked Suppression: Two Critical Suppressive Mechanisms of Human Donor Antigen Specific Regulatory T Cell Lines Expanded Post Transplant. Front Immunol. 2022; 13:849939. PMID: 35371066.
      Citations:    Fields:    Translation:HumansAnimalsCells
    10. Isakov O, Patibandla BK, Christopher KB, Chandraker A, Hod T. Impact of Post-Transplantation Hypomagnesemia on Long-Term Graft and Patient Survival after Transplantation. Kidney Blood Press Res. 2022; 47(5):341-353. PMID: 35196662.
      Citations: 2     Fields:    Translation:Humans
    11. Chandraker A. Introduction: Moving Toward a More Personalized Approach to Kidney Transplantation. Semin Nephrol. 2022 01; 42(1):1. PMID: 35618391.
      Citations:    Fields:    Translation:Humans
    12. Murakami N, Gelfand SL, Sciacca KR, Killeen K, Leiter RE, Adler JT, Chandraker AK, Lakin JR. Inpatient Kidney Palliative Care for Kidney Transplant Recipients With Failing Allografts. Kidney Med. 2022 Feb; 4(2):100398. PMID: 35243310.
      Citations:    
    13. Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, Waikar SS, Chandraker A, Riella LV, Alexander MP, Troost JP, Chen J, Fermin D, Yee JL, Sampson MG, Beck LH, Henderson JM, Greka A, Rennke HG, Weins A. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrol. 2022 01; 33(1):238-252. PMID: 34732507.
      Citations: 49     Fields:    Translation:HumansCells
    14. M Courtwright A, Patel N, Chandraker A, J Goldberg H. Human leukocyte antigen antibody sensitization, lung transplantation, and health equity. Am J Transplant. 2022 03; 22(3):698-704. PMID: 34379882.
      Citations:    Fields:    Translation:Humans
    15. Garg N, Mandelbrot DA, Parajuli S, Aziz F, Astor BC, Chandraker A, Djamali A. The clinical value of donor-derived cell-free DNA measurements in kidney transplantation. Transplant Rev (Orlando). 2021 12; 35(4):100649. PMID: 34507254.
      Citations: 3     Fields:    Translation:Humans
    16. Kauke M, Panayi AC, Safi AF, Haug V, Perry B, Kollar B, Nizzi MC, Broyles J, Annino DJ, Marty FM, Sinha I, Lian CG, Murphy GF, Chandraker A, Pomahac B. Full facial retransplantation in a female patient-Technical, immunologic, and clinical considerations. Am J Transplant. 2021 10; 21(10):3472-3480. PMID: 34033210.
      Citations: 5     Fields:    Translation:Humans
    17. Martin-Moreno PL, Shin HS, Chandraker A. Obesity and Post-Transplant Diabetes Mellitus in Kidney Transplantation. J Clin Med. 2021 Jun 05; 10(11). PMID: 34198724.
      Citations:    
    18. Win TS, Crisler WJ, Dyring-Andersen B, Lopdrup R, Teague JE, Zhan Q, Barrera V, Ho Sui S, Tasigiorgos S, Murakami N, Chandraker A, Tullius SG, Pomahac B, Riella LV, Clark RA. Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection. J Clin Invest. 2021 04 15; 131(8). PMID: 33667197.
      Citations: 4     Fields:    Translation:HumansCellsCTClinical Trials
    19. Palsson R, Chandraker AK, Curhan GC, Rennke HG, McMahon GM, Waikar SS. The association of calcium oxalate deposition in kidney allografts with graft and patient survival. Nephrol Dial Transplant. 2021 Mar 29; 36(4):747. PMID: 30590582.
      Citations:    Fields:    
    20. El Fekih R, Hurley J, Tadigotla V, Alghamdi A, Srivastava A, Coticchia C, Choi J, Allos H, Yatim K, Alhaddad J, Eskandari S, Chu P, Mihali AB, Lape IT, Lima Filho MP, Aoyama BT, Chandraker A, Safa K, Markmann JF, Riella LV, Formica RN, Skog J, Azzi JR. Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection. J Am Soc Nephrol. 2021 Apr; 32(4):994-1004. PMID: 33658284.
      Citations: 21     Fields:    
    21. Zhang H, Wang Z, Zhang J, Gui Z, Han Z, Tao J, Chen H, Sun L, Fei S, Yang H, Tan R, Chandraker A, Gu M. Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation. Front Immunol. 2021; 12:618737. PMID: 33732243.
      Citations: 5     Fields:    Translation:AnimalsCells
    22. Mohammed MT, Cai S, Hanson BL, Zhang H, Clement RL, Daccache J, Cavazzoni CB, Blazar BR, Alessandrini A, Rennke HG, Chandraker A, Sage PT. Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation. Am J Transplant. 2021 05; 21(5):1893-1901. PMID: 33421294.
      Citations: 15     Fields:    Translation:HumansAnimals
    23. Hod T, Isakov O, Patibandla BK, Christopher KB, Hershkoviz R, Schwartz IF, Chandraker A. Posttransplantation Hypomagnesemia as a Predictor of Better Graft Function after Transplantation. Kidney Blood Press Res. 2020; 45(6):982-995. PMID: 33152728.
      Citations: 2     Fields:    Translation:Humans
    24. Cai S, Choi JY, Borges TJ, Zhang H, Miao J, Ichimura T, Li X, Xu S, Chu P, Eskandari SK, Allos H, Alhaddad JB, Muhsin SA, Yatim K, Riella LV, Sage PT, Chandraker AK, Azzi JR. Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo. Sci Rep. 2020 08 28; 10(1):14249. PMID: 32859934.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    25. Palsson R, Chandraker AK, Curhan GC, Rennke HG, McMahon GM, Waikar SS. The association of calcium oxalate deposition in kidney allografts with graft and patient survival. Nephrol Dial Transplant. 2020 05 01; 35(5):888-894. PMID: 30165691.
      Citations: 16     Fields:    Translation:Humans
    26. Wang S, Cai S, Zhang W, Liu X, Li Y, Zhang C, Zeng Y, Xu M, Rong R, Yang T, Shi B, Chandraker A, Yang C, Zhu T. High-mobility group box 1 protein antagonizes the immunosuppressive capacity and therapeutic effect of mesenchymal stem cells in acute kidney injury. J Transl Med. 2020 04 20; 18(1):175. PMID: 32312307.
      Citations: 6     Fields:    Translation:AnimalsCells
    27. Choi J, Chandraker A. Immunologic Risk Assessment and Approach to Immunosuppression Regimen in Kidney Transplantation. Clin Lab Med. 2019 12; 39(4):643-656. PMID: 31668275.
      Citations: 2     Fields:    Translation:Humans
    28. Siedlecki AM, Benson C, Frates M, Azzi J, Hoffman RJ, Milford E, Weins A, Chandraker A, Mc Donald N, Philip White J, Abdi R. First Report of Perfluorobutane Microsphere-Enhanced Ultrasound in the Transplant Kidney. Transplantation. 2019 10; 103(10):e283-e284. PMID: 31335773.
      Citations:    Fields:    Translation:Humans
    29. Starling RC, Armstrong B, Bridges ND, Eisen H, Givertz MM, Kfoury AG, Kobashigawa J, Ikle D, Morrison Y, Pinney S, Stehlik J, Tripathi S, Sayegh MH, Chandraker A. Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation. J Am Coll Cardiol. 2019 07 09; 74(1):36-51. PMID: 31272550.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    30. Tasigiorgos S, Kollar B, Turk M, Perry B, Alhefzi M, Kiwanuka H, Nizzi MC, Marty FM, Chandraker A, Tullius SG, Riella LV, Pomahac B. Five-Year Follow-up after Face Transplantation. N Engl J Med. 2019 06 27; 380(26):2579-2581. PMID: 31141626.
      Citations: 14     Fields:    Translation:Humans
    31. Chandraker A, Andreoni KA, Gaston RS, Gill J, Locke JE, Mathur AK, Norman DJ, Patzer RE, Rana A, Ratner LE, Schold JD, Pruett TL. Time for reform in transplant program-specific reporting: AST/ASTS transplant metrics taskforce. Am J Transplant. 2019 07; 19(7):1888-1895. PMID: 31012525.
      Citations: 9     Fields:    Translation:Humans
    32. Uffing A, Hidalgo LG, McMullan C, Perry J, Milford EL, Murakami N, Yeung MY, Guleria I, Wood IG, Akalin E, Azzi J, Chandraker AK, Riella LV. Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation. Transplant Direct. 2019 May; 5(5):e446. PMID: 31165081.
      Citations:    
    33. Stehlik J, Armstrong B, Baran DA, Bridges ND, Chandraker A, Gordon R, De Marco T, Givertz MM, Heroux A, Ikl? D, Hunt J, Kfoury AG, Madsen JC, Morrison Y, Feller E, Pinney S, Tripathi S, Heeger PS, Starling RC. Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18. Am J Transplant. 2019 05; 19(5):1518-1528. PMID: 30549425.
      Citations: 6     Fields:    Translation:HumansCells
    34. Cai S, Zhao J, Ueno T, Chandraker A. Potential Roles of Siglecs in the Regulation of Allo-Immune Reaction. Curr Protein Pept Sci. 2019; 20(8):823-828. PMID: 31060487.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    35. Cai S, Chandraker A. Cell Therapy in Solid Organ Transplantation. Curr Gene Ther. 2019; 19(2):71-80. PMID: 31161989.
      Citations: 4     Fields:    Translation:HumansCells
    36. Shin HS, Grgic I, Chandraker A. Novel Targets of Immunosuppression in Transplantation. Clin Lab Med. 2019 03; 39(1):157-169. PMID: 30709504.
      Citations: 6     Fields:    Translation:Cells
    37. Gabardi S, Pavlakis M, Tan C, Francis J, Cardarelli F, Asch W, Bodziak K, Chobanian M, Gilligan H, Gohh R, Kung SC, Inker L, Martin S, Rodig N, Rossi A, Chandraker A. New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines. Transpl Infect Dis. 2018 Dec; 20(6):e12985. PMID: 30175491.
      Citations: 1     Fields:    Translation:HumansCells
    38. Murakami N, Ding Y, Cohen DJ, Chandraker AK, Rennke HG. Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir). Transpl Infect Dis. 2018 Oct; 20(5):e12959. PMID: 29968947.
      Citations: 1     Fields:    Translation:HumansCells
    39. D'Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, Bassi R, Tezza S, Dellepiane S, El Essawy B, Iascone M, Iacovoni A, Borgese L, Liu K, Visner G, Dhe-Paganon S, Corradi D, Abdi R, Starling RC, Folli F, Zuccotti GV, Sayegh MH, Heeger PS, Chandraker A, Grigioni F, Fiorina P. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018 08 01; 128(8):3490-3503. PMID: 30010623.
      Citations: 21     Fields:    Translation:HumansCells
    40. Incerti D, Summers N, Ton TGN, Boscoe A, Chandraker A, Stevens W. The Lifetime Health Burden of Delayed Graft Function in Kidney Transplant Recipients in the United States. MDM Policy Pract. 2018 Jan-Jun; 3(1):2381468318781811. PMID: 30288451.
      Citations:    
    41. Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, O'Leary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P. Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. Am J Transplant. 2018 07; 18(7):1604-1614. PMID: 29603613.
      Citations: 50     Fields:    Translation:Humans
    42. Martin-Moreno PL, Tripathi S, Chandraker A. Regulatory T Cells and Kidney Transplantation. Clin J Am Soc Nephrol. 2018 11 07; 13(11):1760-1764. PMID: 29789350.
      Citations: 24     Fields:    Translation:HumansCells
    43. Batal I, Mohan S, De Serres SA, Vasilescu ER, Tsapepas D, Crew RJ, Patel SS, Serban G, McCune K, Husain SA, Chang JH, Herter JM, Bhagat G, Markowitz GS, D'Agati VD, Hardy MA, Ratner L, Chandraker A. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes. Kidney Int. 2018 05; 93(5):1227-1239. PMID: 29544662.
      Citations: 4     Fields:    Translation:HumansCells
    44. Schold JD, Andreoni KA, Chandraker AK, Gaston RS, Locke JE, Mathur AK, Pruett TL, Rana A, Ratner LE, Buccini LD. Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States. Am J Transplant. 2018 06; 18(6):1494-1501. PMID: 29316241.
      Citations: 5     Fields:    Translation:Humans
    45. Fallahian F, Molway D, Jadeja S, Clark R, Marty FM, Riella LV, Chandraker A, Talbot SG. Eponychial lesions following bilateral upper extremity vascular composite allotransplantation: a case report. Case Reports Plast Surg Hand Surg. 2018; 5(1):14-17. PMID: 29441355.
      Citations:    
    46. Grgic I, Chandraker A. Significance of biologics in renal transplantation: past, present, and future. Curr Opin Organ Transplant. 2018 02; 23(1):51-62. PMID: 29176362.
      Citations: 1     Fields:    Translation:HumansAnimals
    47. Sula Karreci E, Eskandari SK, Dotiwala F, Routray SK, Kurdi AT, Assaker JP, Luckyanchykov P, Mihali AB, Maarouf O, Borges TJ, Alkhudhayri A, Patel KR, Radwan A, Ghobrial I, McGrath M, Chandraker A, Riella LV, Elyaman W, Abdi R, Lieberman J, Azzi J. Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation. JCI Insight. 2017 11 02; 2(21). PMID: 29093262.
      Citations: 17     Fields:    Translation:HumansCells
    48. Shin HS, Chandraker A. Causes and management of postrenal transplant diarrhea: an underappreciated cause of transplant-associated morbidity. Curr Opin Nephrol Hypertens. 2017 11; 26(6):484-493. PMID: 28863048.
      Citations: 2     Fields:    Translation:Humans
    49. Park J, Lin HY, Assaker JP, Jeong S, Huang CH, Kurdi T, Lee K, Fraser K, Min C, Eskandari S, Routray S, Tannous B, Abdi R, Riella L, Chandraker A, Castro CM, Weissleder R, Lee H, Azzi JR. Integrated Kidney Exosome Analysis for the Detection of Kidney Transplant Rejection. ACS Nano. 2017 11 28; 11(11):11041-11046. PMID: 29053921.
      Citations: 40     Fields:    Translation:HumansCells
    50. Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Abu Dayyeh B, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N. ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management. Gastrointest Endosc. 2017 11; 86(5):757-767. PMID: 29031371.
      Citations: 2     Fields:    Translation:Humans
    51. D?sy O, B?land S, Vallin P, Riopel J, Latulippe E, Najafian N, Chandraker A, Agharazii M, Batal I, De Serres SA. IL-6 production by monocytes is associated with graft function decline in patients with borderline changes suspicious for acute T-cell-mediated rejection: a pilot study. Transpl Int. 2018 01; 31(1):92-101. PMID: 28906029.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    52. Grimmig T, Moll EM, Kloos K, Thumm R, Moench R, Callies S, Kreckel J, Vetterlein M, Pelz J, Polat B, Tripathi S, Rehder R, Ribas CM, Chandraker A, Germer CT, Waaga-Gasser AM, Gasser M. Upregulated Heat Shock Proteins After Hyperthermic Chemotherapy Point to Induced Cell Survival Mechanisms in Affected Tumor Cells From Peritoneal Carcinomatosis. Cancer Growth Metastasis. 2017; 10:1179064417730559. PMID: 29403306.
      Citations:    
    53. Ryou M, McQuaid KR, Thompson CC, Edmundowicz S, Mergener K, Dayyeh BA, Apovian C, Burke C, Chand B, Chandraker A, Deas T, Dietz W, Dunkin B, Ernest O, Faigel D, Garber S, Hamdy O, Kaplan L, Kumar N, Kushner R, Larsen MC, Lerner H, Littenberg G, Mantzoros C, Mattar S, Moore R, Rinella M, Rothstein R, Schillinger D, Spring B, Sullivan S, Tice J, Vargo J, Wilson E, Woods K, Zundel N. ASGE EndoVators Summit: Defining the role and value of endoscopic therapies in obesity management. Surg Obes Relat Dis. 2017 11; 13(11):1805-1816. PMID: 29030161.
      Citations:    Fields:    Translation:Humans
    54. Zazueta OE, Preston SE, Moniodis A, Fried S, Kim M, Townsend K, Wood I, Boukedes S, Guleria I, Camp P, El-Chemaly S, Rosas IO, Chandraker A, Milford E, Goldberg HJ. The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death. Transplantation. 2017 09; 101(9):2207-2212. PMID: 27893614.
      Citations: 9     Fields:    Translation:Humans
    55. Win TS, Murakami N, Borges TJ, Chandraker A, Murphy G, Lian C, Barrera V, Ho Sui S, Schoenfeld D, Teague J, Bueno E, Tullius SG, Pomahac B, Clark RA, Riella LV. Longitudinal immunological characterization of the first presensitized recipient of a face transplant. JCI Insight. 2017 Jul 06; 2(13). PMID: 28679959.
      Citations: 4     Fields:    
    56. Rinkinen J, Molway D, Carty M, Dyer GSM, Pomahac B, Chandraker A, Talbot SG. Avascular necrosis of the humeral head following bilateral upper extremity vascular composite allotransplantation: a case report. Case Reports Plast Surg Hand Surg. 2017; 4(1):60-64. PMID: 28804740.
      Citations:    
    57. Giwa S, Lewis JK, Alvarez L, Langer R, Roth AE, Church GM, Markmann JF, Sachs DH, Chandraker A, Wertheim JA, Rothblatt M, Boyden ES, Eidbo E, Lee WPA, Pomahac B, Brandacher G, Weinstock DM, Elliott G, Nelson D, Acker JP, Uygun K, Schmalz B, Weegman BP, Tocchio A, Fahy GM, Storey KB, Rubinsky B, Bischof J, Elliott JAW, Woodruff TK, Morris GJ, Demirci U, Brockbank KGM, Woods EJ, Ben RN, Baust JG, Gao D, Fuller B, Rabin Y, Kravitz DC, Taylor MJ, Toner M. The promise of organ and tissue preservation to transform medicine. Nat Biotechnol. 2017 06 07; 35(6):530-542. PMID: 28591112.
      Citations: 148     Fields:    Translation:Humans
    58. DeWolfe D, Gandhi J, Mackenzie MR, Broge TA, Bord E, Babwah A, Mandelbrot DA, Pavlakis M, Cardarelli F, Viscidi R, Chandraker A, Tan CS. Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients. PLoS One. 2017; 12(5):e0177339. PMID: 28562595.
      Citations: 4     Fields:    Translation:HumansCells
    59. Asare A, Kanaparthi S, Lim N, Phippard D, Vincenti F, Friedewald J, Pavlakis M, Poggio E, Heeger P, Mannon R, Burrell BE, Morrison Y, Bridges N, Sanz I, Chandraker A, Newell KA, Turka LA. B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function. Am J Transplant. 2017 Oct; 17(10):2627-2639. PMID: 28371372.
      Citations: 11     Fields:    Translation:HumansCells
    60. Jiamjariyapon T, Ingsathit A, Pongpirul K, Vipattawat K, Kanchanakorn S, Saetie A, Kanistanon D, Wongprompitak P, Leesmidt V, Watcharasaksilp W, Wang W, Chandraker AK, Tungsanga K. Effectiveness of Integrated Care on Delaying Progression of stage 3-4 Chronic Kidney Disease in Rural Communities of Thailand (ESCORT study): a cluster randomized controlled trial. BMC Nephrol. 2017 03 02; 18(1):83. PMID: 28253839.
      Citations: 28     Fields:    Translation:Humans
    61. Newell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A. Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference. Am J Transplant. 2017 04; 17(4):901-911. PMID: 27997071.
      Citations: 25     Fields:    Translation:Humans
    62. Bassi R, Niewczas MA, Biancone L, Bussolino S, Merugumala S, Tezza S, D'Addio F, Ben Nasr M, Valderrama-Vasquez A, Usuelli V, De Zan V, El Essawy B, Venturini M, Secchi A, De Cobelli F, Lin A, Chandraker A, Fiorina P. Metabolomic Profiling in Individuals with a Failing Kidney Allograft. PLoS One. 2017; 12(1):e0169077. PMID: 28052095.
      Citations: 18     Fields:    Translation:Humans
    63. Grimmig T, Moench R, Kreckel J, Haack S, Rueckert F, Rehder R, Tripathi S, Ribas C, Chandraker A, Germer CT, Gasser M, Waaga-Gasser AM. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer. Int J Mol Sci. 2016 Dec 08; 17(12). PMID: 27941651.
      Citations: 32     Fields:    Translation:HumansCells
    64. Cardarelli F, Bijol V, Chandraker A, Varga C, Riella LV. Acute myeloid leukemia after kidney transplantation: a case report and literature review. J Bras Nefrol. 2016 Dec; 38(4):455-461. PMID: 28001189.
      Citations:    Fields:    Translation:Humans
    65. Moench R, Grimmig T, Kannen V, Tripathi S, Faber M, Moll EM, Chandraker A, Lissner R, Germer CT, Waaga-Gasser AM, Gasser M. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer. Oncotarget. 2016 Oct 18; 7(42):68749-68767. PMID: 27626684.
      Citations: 24     Fields:    Translation:HumansCells
    66. Ueno T, Kim P, McGrath MM, Yeung MY, Shimizu T, Jung K, Sayegh MH, Chandraker AK, Abdi R, Yun SH. Live Images of Donor Dendritic Cells Trafficking via CX3CR1 Pathway. Front Immunol. 2016; 7:412. PMID: 27790214.
      Citations: 4     Fields:    
    67. Pruett TL, Vathsala A, Berney T, Lerut J, Odorico JS, Johnson M, Egawa H, Gonzalez-Martinez F, Haberal M, Ascher NL, Chandraker AK. Criminal Organ Retrieval: Unconscionable. Am J Transplant. 2017 02; 17(2):577. PMID: 27696661.
      Citations:    Fields:    Translation:Humans
    68. Chandraker A, Arscott R, Murphy G, Lian C, Bueno E, Marty F, Rennke H, Milford E, Tullius S, Pomahac B. Face Transplantation in a Highly Sensitized Recipient. Mil Med. 2016 10; 181(10):1392. PMID: 27753587.
      Citations:    Fields:    
    69. Weissenbacher A, Loupy A, Chandraker A, Schneeberger S. Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant. 2016 10; 21(5):510-5. PMID: 27517505.
      Citations: 5     Fields:    Translation:Humans
    70. Ueno T, Jung K, Yeung MY, McGrath MM, Shimizu T, Kim P, Sayegh MH, Chandraker A, Yun SH. Imaging cell biology in transplantation. Transpl Int. 2016 Dec; 29(12):1349-1351. PMID: 27570933.
      Citations: 2     Fields:    Translation:Animals
    71. Pruett TL, Chandraker A. The White House Organ Summit: What It Means for Our Field. Am J Transplant. 2016 08; 16(8):2245-6. PMID: 27441777.
      Citations: 2     Fields:    Translation:Humans
    72. Javaheri A, Molina M, Zamani P, Rodrigues A, Novak E, Chambers S, Stutman P, Maslanek W, Williams M, Lilly SM, Heeger P, Sayegh MH, Chandraker A, Briscoe DM, Daly KP, Starling R, Ikle D, Christie J, Rame JE, Goldberg LR, Billheimer J, Rader DJ. Cholesterol efflux capacity of high-density lipoprotein correlates with survival and allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2016 11; 35(11):1295-1302. PMID: 27498384.
      Citations: 7     Fields:    Translation:Humans
    73. Lin MV, Sise ME, Pavlakis M, Amundsen BM, Chute D, Rutherford AE, Chung RT, Curry MP, Hanifi JM, Gabardi S, Chandraker A, Heher EC, Elias N, Riella LV. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection. PLoS One. 2016; 11(7):e0158431. PMID: 27415632.
      Citations: 32     Fields:    Translation:Humans
    74. Ueno T, Ikeda T, Yokoyama T, Kihara Y, Konno O, Nakamura Y, Iwamoto H, Shimizu T, McGrath MM, Chandraker A. Reduction in circulating level of HMGB-1 following continuous renal replacement therapy in sepsis. Cytokine. 2016 07; 83:206-209. PMID: 27155819.
      Citations: 6     Fields:    Translation:Humans
    75. Chandraker A, Arscott R, Murphy G, Lian C, Bueno E, Marty F, Rennke H, Milford E, Tullius S, Pomahac B. Face Transplantation in a Highly Sensitized Recipient. Mil Med. 2016 05; 181(5 Suppl):221-6. PMID: 27168576.
      Citations:    Fields:    Translation:Humans
    76. Borges TJ, O'Malley JT, Wo L, Murakami N, Smith B, Azzi J, Tripathi S, Lane JD, Bueno EM, Clark RA, Tullius SG, Chandraker A, Lian CG, Murphy GF, Strom TB, Pomahac B, Najafian N, Riella LV. Codominant Role of Interferon-?- and Interleukin-17-Producing T Cells During Rejection in Full Facial Transplant Recipients. Am J Transplant. 2016 07; 16(7):2158-71. PMID: 26749226.
      Citations: 17     Fields:    Translation:HumansCells
    77. Ito T, Yamada A, Batal I, Yeung MY, McGrath MM, Sayegh MH, Chandraker A, Ueno T. The Limits of Linked Suppression for Regulatory T Cells. Front Immunol. 2016; 7:82. PMID: 27014262.
      Citations: 2     Fields:    
    78. Chandraker A. The Real World Impact of APOL1 Variants on Kidney Transplantation. Transplantation. 2016 Jan; 100(1):16-7. PMID: 26566059.
      Citations: 4     Fields:    Translation:Humans
    79. Hod T, Riella LV, Chandraker A. Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case report. Clin Transplant. 2015 Nov; 29(11):951-7. PMID: 26331695.
      Citations: 3     Fields:    Translation:Humans
    80. Starling RC, Stehlik J, Baran DA, Armstrong B, Stone JR, Ikle D, Morrison Y, Bridges ND, Putheti P, Strom TB, Bhasin M, Guleria I, Chandraker A, Sayegh M, Daly KP, Briscoe DM, Heeger PS. Multicenter Analysis of Immune Biomarkers and Heart Transplant Outcomes: Results of the Clinical Trials in Organ Transplantation-05 Study. Am J Transplant. 2016 Jan; 16(1):121-36. PMID: 26260101.
      Citations: 20     Fields:    Translation:Humans
    81. Grimmig T, Matthes N, Hoeland K, Tripathi S, Chandraker A, Grimm M, Moench R, Moll EM, Friess H, Tsaur I, Blaheta RA, Germer CT, Waaga-Gasser AM, Gasser M. TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer. Int J Oncol. 2015 Sep; 47(3):857-66. PMID: 26134824.
      Citations: 37     Fields:    Translation:HumansAnimalsCells
    82. Gabardi S, Ramasamy S, Kim M, Klasek R, Carter D, Mackenzie MR, Chandraker A, Tan CS. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia. Transpl Infect Dis. 2015 Aug; 17(4):536-43. PMID: 25989423.
      Citations: 3     Fields:    Translation:HumansCells
    83. Batal I, De Serres SA, Safa K, Bijol V, Ueno T, Onozato ML, Iafrate AJ, Herter JM, Lichtman AH, Mayadas TN, Guleria I, Rennke HG, Najafian N, Chandraker A. Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft Survival. J Am Soc Nephrol. 2015 Dec; 26(12):3102-13. PMID: 25855773.
      Citations: 14     Fields:    Translation:HumansCells
    84. Safa K, Ohori S, Borges TJ, Uehara M, Batal I, Shimizu T, Magee CN, Belizaire R, Abdi R, Wu C, Chandraker A, Riella LV. Salt Accelerates Allograft Rejection through Serum- and Glucocorticoid-Regulated Kinase-1-Dependent Inhibition of Regulatory T Cells. J Am Soc Nephrol. 2015 Oct; 26(10):2341-7. PMID: 25833841.
      Citations: 27     Fields:    Translation:AnimalsCells
    85. Fischer S, Lian CG, Kueckelhaus M, Strom TB, Edelman ER, Clark RA, Murphy GF, Chandraker AK, Riella LV, Tullius SG, Pomahac B. Acute rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant. 2014 Dec; 19(6):531-44. PMID: 25333831.
      Citations: 28     Fields:    Translation:HumansAnimals
    86. Riella LV, Safa K, Yagan J, Lee B, Azzi J, Najafian N, Abdi R, Milford E, Mah H, Gabardi S, Malek S, Tullius SG, Magee C, Chandraker A. Long-term outcomes of kidney transplantation across a positive complement-dependent cytotoxicity crossmatch. Transplantation. 2014 Jun 27; 97(12):1247-52. PMID: 24854670.
      Citations: 15     Fields:    Translation:Humans
    87. Batal I, De Serres SA, Mfarrej BG, Grafals M, Pinkus GS, Kalra A, Weins A, Bijol V, Rennke HG, Guleria I, Abdi R, Chandraker A, Najafian N. Glomerular inflammation correlates with endothelial injury and with IL-6 and IL-1? secretion in the peripheral blood. Transplantation. 2014 May 27; 97(10):1034-42. PMID: 24406453.
      Citations: 10     Fields:    Translation:HumansCells
    88. Kim M, Townsend KR, Wood IG, Boukedes S, Guleria I, Gabardi S, El-Chemaly S, Camp PC, Chandraker AK, Milford EL, Goldberg HJ. Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates. Am J Respir Crit Care Med. 2014 May 15; 189(10):1234-9. PMID: 24749479.
      Citations: 21     Fields:    Translation:Humans
    89. Chandraker A, Arscott R, Murphy GF, Lian CG, Bueno EM, Marty FM, Rennke HG, Milford E, Tullius SG, Pomahac B. The management of antibody-mediated rejection in the first presensitized recipient of a full-face allotransplant. Am J Transplant. 2014 Jun; 14(6):1446-52. PMID: 24797454.
      Citations: 22     Fields:    Translation:Humans
    90. Lee BT, Gabardi S, Grafals M, Hofmann RM, Akalin E, Aljanabi A, Mandelbrot DA, Adey DB, Heher E, Fan PY, Conte S, Dyer-Ward C, Chandraker A. Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial. Clin J Am Soc Nephrol. 2014 Mar; 9(3):583-9. PMID: 24482066.
      Citations: 25     Fields:    Translation:HumansCells
    91. Lian CG, Bueno EM, Granter SR, Laga AC, Saavedra AP, Lin WM, Susa JS, Zhan Q, Chandraker AK, Tullius SG, Pomahac B, Murphy GF. Biomarker evaluation of face transplant rejection: association of donor T cells with target cell injury. Mod Pathol. 2014 Jun; 27(6):788-99. PMID: 24434898.
      Citations: 33     Fields:    Translation:HumansCells
    92. Vergani A, Tezza S, Fotino C, Visner G, Pileggi A, Chandraker A, Fiorina P. The purinergic system in allotransplantation. Am J Transplant. 2014 Mar; 14(3):507-14. PMID: 24433446.
      Citations: 18     Fields:    Translation:HumansAnimals
    93. Safa K, Riella LV, Chandraker A. Beyond calcineurin inhibitors: emerging agents in kidney transplantation. Curr Opin Nephrol Hypertens. 2013 Nov; 22(6):689-97. PMID: 24100221.
      Citations: 7     Fields:    Translation:HumansCells
    94. Chandraker A, Strom TB. Transplantation: a new molecular approach to the diagnosis of acute rejection. Nat Rev Nephrol. 2013 Nov; 9(11):631-2. PMID: 24080796.
      Citations:    Fields:    Translation:Humans
    95. Zandi-Nejad K, Takakura A, Jurewicz M, Chandraker AK, Offermanns S, Mount D, Abdi R. The role of HCA2 (GPR109A) in regulating macrophage function. FASEB J. 2013 Nov; 27(11):4366-74. PMID: 23882124.
      Citations: 50     Fields:    Translation:AnimalsCells
    96. Townamchai N, Safa K, Chandraker A. Immunologic monitoring in kidney transplant recipients. Kidney Res Clin Pract. 2013 Jun; 32(2):52-61. PMID: 26877913.
      Citations:    
    97. Gabardi S, Townsend K, Martin ST, Chandraker A. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients. Transpl Infect Dis. 2013 Aug; 15(4):361-8. PMID: 23647907.
      Citations: 6     Fields:    Translation:HumansCells
    98. Riella LV, Yang J, Chock S, Safa K, Magee CN, Vanguri V, Elyaman W, Lahoud Y, Yagita H, Abdi R, Najafian N, Medina-Pestana JO, Chandraker A. Jagged2-signaling promotes IL-6-dependent transplant rejection. Eur J Immunol. 2013 Jun; 43(6):1449-58. PMID: 23526606.
      Citations: 18     Fields:    Translation:AnimalsCells
    99. Daly KP, Seifert ME, Chandraker A, Zurakowski D, Nohria A, Givertz MM, Karumanchi SA, Briscoe DM. VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2013 Jan; 32(1):120-8. PMID: 23260712.
      Citations: 31     Fields:    Translation:Humans
    100. Riella LV, Paterson AM, Sharpe AH, Chandraker A. Role of the PD-1 pathway in the immune response. Am J Transplant. 2012 Oct; 12(10):2575-87. PMID: 22900886.
      Citations: 182     Fields:    Translation:HumansCells
    101. Riella LV, Chandraker A. Stem cell therapy in kidney transplantation. JAMA. 2012 Jul 11; 308(2):130; author reply 130-1. PMID: 22782400.
      Citations: 6     Fields:    Translation:Humans
    102. Riella LV, Gabardi S, Chandraker A. Dyslipidemia and its therapeutic challenges in renal transplantation. Am J Transplant. 2012 Aug; 12(8):1975-82. PMID: 22578270.
      Citations: 20     Fields:    Translation:Humans
    103. De Serres SA, Mfarrej BG, Grafals M, Riella LV, Magee CN, Yeung MY, Dyer C, Ahmad U, Chandraker A, Najafian N. Derivation and validation of a cytokine-based assay to screen for acute rejection in renal transplant recipients. Clin J Am Soc Nephrol. 2012 Jun; 7(6):1018-25. PMID: 22498498.
      Citations: 12     Fields:    Translation:HumansCells
    104. Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation. Clin Transplant. 2012 May-Jun; 26(3):E184-90. PMID: 22487221.
      Citations: 13     Fields:    Translation:HumansAnimalsCTClinical Trials
    105. Lee BT, Kumar V, Williams TA, Abdi R, Bernhardy A, Dyer C, Conte S, Genovese G, Ross MD, Friedman DJ, Gaston R, Milford E, Pollak MR, Chandraker A. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant. 2012 Jul; 12(7):1924-8. PMID: 22487534.
      Citations: 96     Fields:    Translation:Humans
    106. Riella LV, Liu T, Yang J, Chock S, Shimizu T, Mfarrej B, Batal I, Xiao X, Sayegh MH, Chandraker A. Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model. Am J Transplant. 2012 Apr; 12(4):846-55. PMID: 22300534.
      Citations: 66     Fields:    Translation:AnimalsCells
    107. Sheashaa HA, Rennke HG, Bakr MA, Abbas TM, Atta AF, Sangak A, Mah H, Milford E, Chandraker A. Impact of accidental discovery of renal cell carcinoma at time of renal transplantation on patient or graft survival. Transplantation. 2011 Nov 27; 92(10):1123-8. PMID: 21956203.
      Citations: 1     Fields:    Translation:Humans
    108. Riella LV, Ueno T, Batal I, De Serres SA, Bassil R, Elyaman W, Yagita H, Medina-Pestana JO, Chandraker A, Najafian N. Blockade of Notch ligand d1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation. J Immunol. 2011 Nov 01; 187(9):4629-38. PMID: 21949024.
      Citations: 22     Fields:    Translation:AnimalsCells
    109. Gabardi S, Catella J, Martin ST, Perrone R, Chandraker A, Magee CC, McDevitt-Potter LM. Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients. Ann Pharmacother. 2011 Sep; 45(9):e48. PMID: 21811001.
      Citations: 1     Fields:    Translation:Humans
    110. Yang J, Riella LV, Chock S, Liu T, Zhao X, Yuan X, Paterson AM, Watanabe T, Vanguri V, Yagita H, Azuma M, Blazar BR, Freeman GJ, Rodig SJ, Sharpe AH, Chandraker A, Sayegh MH. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo. J Immunol. 2011 Aug 01; 187(3):1113-9. PMID: 21697455.
      Citations: 64     Fields:    Translation:AnimalsCells
    111. Paterson AM, Brown KE, Keir ME, Vanguri VK, Riella LV, Chandraker A, Sayegh MH, Blazar BR, Freeman GJ, Sharpe AH. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo. J Immunol. 2011 Aug 01; 187(3):1097-105. PMID: 21697456.
      Citations: 105     Fields:    Translation:AnimalsCells
    112. Tsaur I, Karalis A, Blaheta R, Juengel E, Vallo S, Scheuermann EH, Kachel HG, Waaga-Gasser AM, Chandraker A, Oberm?ller N, Probst M. Transitional cell carcinoma of the native urinary tract after kidney transplantation: recommendations following a long-term retrospective analysis. Am J Med Sci. 2011 Jun; 341(6):478-83. PMID: 21412138.
      Citations: 5     Fields:    Translation:Humans
    113. Martin ST, Roberts KL, Malek SK, Tullius SG, Vadivel N, De Serres S, Grafals M, Elsanjak A, Filkins BA, Chandraker A, Gabardi S. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal. Pharmacotherapy. 2011 Jun; 31(6):566-73. PMID: 21923440.
      Citations: 5     Fields:    Translation:HumansAnimals
    114. De Serres SA, Vadivel N, Mfarrej BG, Grafals M, DeJoseph M, Dyer C, Magee CN, Chandraker A, Gallon LG, Najafian N. Monocyte-secreted inflammatory cytokines are associated with transplant glomerulopathy in renal allograft recipients. Transplantation. 2011 Mar 15; 91(5):552-9. PMID: 21150704.
      Citations: 10     Fields:    Translation:HumansCells
    115. Riella LV, Watanabe T, Sage PT, Yang J, Yeung M, Azzi J, Vanguri V, Chandraker A, Sharpe AH, Sayegh MH, Najafian N. Essential role of PDL1 expression on nonhematopoietic donor cells in acquired tolerance to vascularized cardiac allografts. Am J Transplant. 2011 Apr; 11(4):832-40. PMID: 21401869.
      Citations: 27     Fields:    Translation:AnimalsCells
    116. Lin J, McGovern ME, Brunelli SM, Gaccione P, Malek S, Tullius SG, Chandraker AK, Milford EL. Longitudinal trends and influence of BMI mismatch in living kidney donors and their recipients. Int Urol Nephrol. 2011 Sep; 43(3):891-7. PMID: 21384099.
      Citations: 4     Fields:    Translation:Humans
    117. Riella LV, Rennke HG, Grafals M, Chandraker A. Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy. Am J Kidney Dis. 2011 Apr; 57(4):641-5. PMID: 21333424.
      Citations: 7     Fields:    Translation:Humans
    118. Tsaur I, Gasser M, Aviles B, Lutz J, Lutz L, Grimm M, Lange V, Lopau K, Heemann U, Germer CT, Chandraker A, Waaga-Gasser AM. Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients. Kidney Int. 2011 May; 79(9):1005-12. PMID: 21270769.
      Citations: 14     Fields:    Translation:HumansCells
    119. Bedi DS, Riella LV, Tullius SG, Chandraker A. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction. Transplantation. 2010 Nov 15; 90(9):935-44. PMID: 20703180.
      Citations: 17     Fields:    Translation:HumansAnimals
    120. Lin J, Kramer H, Chandraker AK. Mortality among living kidney donors and comparison populations. N Engl J Med. 2010 Aug 19; 363(8):797-8. PMID: 20818884.
      Citations: 9     Fields:    Translation:Humans
    121. Gabardi S, Waikar SS, Martin S, Roberts K, Chen J, Borgi L, Sheashaa H, Dyer C, Malek SK, Tullius SG, Vadivel N, Grafals M, Abdi R, Najafian N, Milford E, Chandraker A. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010 Jul; 5(7):1298-304. PMID: 20507960.
      Citations: 28     Fields:    Translation:HumansCells
    122. Vadivel N, Surana SP, Galvez-Trevino R, Chandraker AK. Quiz page May 2010: debilitating pain of the hands and feet following kidney transplant. Am J Kidney Dis. 2010 May; 55(5):A33-5. PMID: 20438983.
      Citations:    Fields:    Translation:Humans
    123. Erickson AL, Roberts K, Malek SK, Chandraker AK, Tullius SG, Gabardi S. Analysis of infusion-site reactions in renal transplant recipients receiving peripherally administered rabbit antithymocyte globulin as compared with basiliximab. Transpl Int. 2010 Jun; 23(6):636-40. PMID: 20074083.
      Citations: 2     Fields:    Translation:HumansAnimals
    124. Yang J, Riella LV, Boenisch O, Popoola J, Robles S, Watanabe T, Vanguri V, Yuan X, Guleria I, Turka LA, Sayegh MH, Chandraker A. Paradoxical functions of B7: CD28 costimulation in a MHC class II-mismatched cardiac transplant model. Am J Transplant. 2009 Dec; 9(12):2837-44. PMID: 19845593.
      Citations: 13     Fields:    Translation:AnimalsCells
    125. Waaga-Gasser AM, Grimm MR, Lutz J, Lange V, Lenhard SM, Aviles B, Kist-van Holthe JE, Lebedeva T, Samsonov D, Meyer D, Hancock WW, Heemann U, Gasser M, Chandraker A. Regulatory allospecific T cell clones abrogate chronic allograft rejection. J Am Soc Nephrol. 2009 Apr; 20(4):820-30. PMID: 19297560.
      Citations: 5     Fields:    Translation:AnimalsCells
    126. Grafals M, Chandraker A. New approaches for desensitization strategies prior to kidney transplantation. Am J Kidney Dis. 2009 Mar; 53(3):370-2. PMID: 19231737.
      Citations: 3     Fields:    
    127. Boenisch O, Chandraker A. Predictive biomarkers of renal allograft failure. Expert Opin Med Diagn. 2008 Nov; 2(11):1279-90. PMID: 23496686.
      Citations: 1     Fields:    
    128. Pomahac B, Aflaki P, Chandraker A, Pribaz JJ. Facial transplantation and immunosuppressed patients: a new frontier in reconstructive surgery. Transplantation. 2008 Jun 27; 85(12):1693-7. PMID: 18580458.
      Citations: 3     Fields:    Translation:Humans
    129. Winkelmayer WC, Chandraker A. Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol. 2008 Mar; 3 Suppl 2:S49-55. PMID: 18309003.
      Citations: 18     Fields:    Translation:Humans
    130. Chandraker A, Mannon RB. Care of the kidney transplant recipient. Clin J Am Soc Nephrol. 2008 Mar; 3 Suppl 2:S27-8. PMID: 18309000.
      Citations:    Fields:    Translation:Humans
    131. Yang J, Popoola J, Khandwala S, Vadivel N, Vanguri V, Yuan X, Dada S, Guleria I, Tian C, Ansari MJ, Shin T, Yagita H, Azuma M, Sayegh MH, Chandraker A. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation. 2008 Feb 05; 117(5):660-9. PMID: 18212277.
      Citations: 41     Fields:    Translation:HumansAnimalsCells
    132. Huurman VA, Unger WW, Koeleman BP, Oaks MK, Chandraker AK, Terpstra OT, Roep BO. Differential inhibition of autoreactive memory- and alloreactive naive T cell responses by soluble cytotoxic T lymphocyte antigen 4 (sCTLA4), CTLA4Ig and LEA29Y. Clin Exp Immunol. 2007 Dec; 150(3):487-93. PMID: 17924973.
      Citations: 15     Fields:    Translation:HumansCells
    133. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007 Aug; 13(8):952-61. PMID: 17660828.
      Citations: 1052     Fields:    Translation:HumansAnimalsCells
    134. Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transpl Int. 2007 Dec; 20(12):993-1015. PMID: 17617181.
      Citations: 12     Fields:    Translation:Humans
    135. Vadivel N, Tullius SG, Chandraker A. Chronic allograft nephropathy. Semin Nephrol. 2007 Jul; 27(4):414-29. PMID: 17616274.
      Citations: 9     Fields:    Translation:Humans
    136. Vadivel N, Trikudanathan S, Chandraker A. Transplant tolerance through costimulation blockade--are we there yet? Front Biosci. 2007 May 01; 12:2935-46. PMID: 17485270.
      Citations: 3     Fields:    Translation:HumansAnimals
    137. Winkelmayer WC, Mehta J, Chandraker A, Owen WF, Avorn J. Predialysis nephrologist care and access to kidney transplantation in the United States. Am J Transplant. 2007 Apr; 7(4):872-9. PMID: 17391130.
      Citations: 16     Fields:    Translation:Humans
    138. Winkelmayer WC, Schaeffner ES, Chandraker A, Kramar R, Rumpold H, Sunder-Plassmann G, F?dinger M. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int. 2007 Jun; 20(6):505-11. PMID: 17362474.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    139. Ali SH, Chandraker A, DeCaprio JA. Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones. Antivir Ther. 2007; 12(1):1-6. PMID: 17503741.
      Citations: 24     Fields:    Translation:HumansCells
    140. Winkelmayer WC, Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006 Dec; 21(12):3559-66. PMID: 17040993.
      Citations: 20     Fields:    Translation:Humans
    141. Pendse SS, Vadivel N, Ramos E, Mudge GH, Von Visger T, Fang JC, Chandraker A. BK viral reactivation in cardiac transplant patients: evidence for a double-hit hypothesis. J Heart Lung Transplant. 2006 Jul; 25(7):814-9. PMID: 16818124.
      Citations: 8     Fields:    Translation:HumansCells
    142. Josephson MA, Williams JW, Chandraker A, Randhawa PS. Polyomavirus-associated nephropathy: update on antiviral strategies. Transpl Infect Dis. 2006 Jun; 8(2):95-101. PMID: 16734632.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    143. Martins PN, Chandraker A, Tullius SG. Modifying graft immunogenicity and immune response prior to transplantation: potential clinical applications of donor and graft treatment. Transpl Int. 2006 May; 19(5):351-9. PMID: 16623870.
      Citations: 14     Fields:    Translation:Humans
    144. Tinckam KJ, Chandraker A. Mechanisms and role of HLA and non-HLA alloantibodies. Clin J Am Soc Nephrol. 2006 May; 1(3):404-14. PMID: 17699239.
      Citations: 12     Fields:    Translation:Humans
    145. Chandraker A, Tullius SG. Induction therapy: are we picking our battles? Clin J Am Soc Nephrol. 2006 May; 1(3):356-7. PMID: 17699231.
      Citations: 1     Fields:    Translation:Humans
    146. Sayegh MH, Chandraker A. Does belatacept provide equivalent suppression of acute renal transplant rejection to ciclosporin? Nat Clin Pract Nephrol. 2006 Mar; 2(3):134-5. PMID: 16932411.
      Citations:    Fields:    
    147. Ansari MJ, Tinckam K, Chandraker A. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005 May 12; 352(19):2027-8; author reply 2027-8. PMID: 15892197.
      Citations: 3     Fields:    Translation:Humans
    148. Chandraker A, Huurman V, Hallett K, Yuan X, Tector AJ, Park CH, Lu E, Zavazava N, Oaks M. CTLA-4 is important in maintaining long-term survival of cardiac allografts. Transplantation. 2005 Apr 27; 79(8):897-903. PMID: 15849541.
      Citations: 6     Fields:    Translation:AnimalsCells
    149. Winkelmayer WC, Kramar R, Curhan GC, Chandraker A, Endler G, F?dinger M, H?rl WH, Sunder-Plassmann G. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005 Jan; 16(1):255-60. PMID: 15563562.
      Citations: 12     Fields:    Translation:Humans
    150. Gabardi S, Magee CC, Baroletti SA, Powelson JA, Cina JL, Chandraker AK. Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis. Pharmacotherapy. 2004 Oct; 24(10):1323-30. PMID: 15628830.
      Citations: 9     Fields:    Translation:Humans
    151. Winkelmayer WC, Kewalramani R, Rutstein M, Gabardi S, Vonvisger T, Chandraker A. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004 May; 15(5):1347-52. PMID: 15100376.
      Citations: 18     Fields:    Translation:Humans
    152. Imitola J, Comabella M, Chandraker AK, Dangond F, Sayegh MH, Snyder EY, Khoury SJ. Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli. Am J Pathol. 2004 May; 164(5):1615-25. PMID: 15111308.
      Citations: 33     Fields:    Translation:AnimalsCells
    153. Izawa A, Sayegh MH, Chandraker A. The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction? Transplant Proc. 2004 Mar; 36(2 Suppl):570S-573S. PMID: 15041407.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    154. Gasser M, Waaga-Gasser AM, Kist-van Holthe JE, Yuan X, Lenhard SM, Abdallah KA, Chandraker A. Chronic rejection: insights from a novel immunosuppressive-free model of kidney transplantation. J Am Soc Nephrol. 2004 Mar; 15(3):687-94. PMID: 14978170.
      Citations: 1     Fields:    Translation:AnimalsCells
    155. Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimi AB. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation. 2003 Sep 15; 76(5):798-802. PMID: 14501856.
      Citations: 42     Fields:    Translation:HumansCTClinical Trials
    156. Salama AD, Yuan X, Nayer A, Chandraker A, Inobe M, Uede T, Sayegh MH. Interaction between ICOS-B7RP1 and B7-CD28 costimulatory pathways in alloimmune responses in vivo. Am J Transplant. 2003 Apr; 3(4):390-5. PMID: 12694060.
      Citations: 9     Fields:    Translation:AnimalsCells
    157. Yuan X, Salama AD, Dong V, Schmitt I, Najafian N, Chandraker A, Akiba H, Yagita H, Sayegh MH. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo. J Immunol. 2003 Mar 15; 170(6):2949-55. PMID: 12626546.
      Citations: 23     Fields:    Translation:AnimalsCellsPHPublic Health
    158. Kist-van Holthe JE, Gasser M, Womer K, Najafian N, Dong V, Samsonov DV, Geehan CS, Chandraker A, Sayegh MH, Waaga AM. Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int. 2002 Aug; 62(2):627-31. PMID: 12110027.
      Citations: 10     Fields:    Translation:HumansCells
    159. Yuan X, Dong VM, Coito AJ, Waaga AM, Salama AD, Benjamin CD, Sayegh MH, Chandraker A. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection. Transplantation. 2002 Jun 15; 73(11):1736-42. PMID: 12084995.
      Citations: 2     Fields:    Translation:AnimalsCells
    160. Dong VM, Yuan X, Coito AJ, Waaga AM, Sayegh MH, Chandraker A. Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection. Transplantation. 2002 Apr 27; 73(8):1310-7. PMID: 11981427.
      Citations: 5     Fields:    Translation:AnimalsCells
    161. Yamada A, Chandraker A, Laufer TM, Gerth AJ, Sayegh MH, Auchincloss H. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol. 2001 Nov 15; 167(10):5522-6. PMID: 11698419.
      Citations: 31     Fields:    Translation:AnimalsCells
    162. Azuma H, Takahara S, Matsumoto K, Ichimaru N, Wang JD, Moriyama T, Waaga AM, Kitamura M, Otsuki Y, Okuyama A, Katsuoka Y, Chandraker A, Sayegh MH, Nakamura T. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol. 2001 Jun; 12(6):1280-1292. PMID: 11373353.
      Citations: 16     Fields:    Translation:Animals
    163. Waaga AM, Gasser M, Kist-van Holthe JE, Najafian N, M?ller A, Vella JP, Womer KL, Chandraker A, Khoury SJ, Sayegh MH. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo. J Clin Invest. 2001 Apr; 107(7):909-16. PMID: 11285310.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    164. Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis. Am J Pathol. 2001 Mar; 158(3):977-86. PMID: 11238045.
      Citations: 12     Fields:    Translation:AnimalsCells
    165. Tzianabos AO, Chandraker A, Kalka-Moll W, Stingele F, Dong VM, Finberg RW, Peach R, Sayegh MH. Bacterial pathogens induce abscess formation by CD4(+) T-cell activation via the CD28-B7-2 costimulatory pathway. Infect Immun. 2000 Dec; 68(12):6650-5. PMID: 11083777.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    166. Goes N, Chandraker A. Human leukocyte antigen matching in renal transplantation: an update. Curr Opin Nephrol Hypertens. 2000 Nov; 9(6):683-7. PMID: 11128432.
      Citations: 1     Fields:    Translation:Humans
    167. Issazadeh S, Abdallah K, Chitnis T, Chandraker A, Wells AD, Turka LA, Sayegh MH, Khoury SJ. Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis. J Clin Invest. 2000 Apr; 105(8):1109-16. PMID: 10772655.
      Citations: 7     Fields:    Translation:AnimalsCells
    168. Reynolds J, Tam FW, Chandraker A, Smith J, Karkar AM, Cross J, Peach R, Sayegh MH, Pusey CD. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest. 2000 Mar; 105(5):643-51. PMID: 10712436.
      Citations: 41     Fields:    Translation:AnimalsCells
    169. Guttormsen HK, Sharpe AH, Chandraker AK, Brigtsen AK, Sayegh MH, Kasper DL. Cognate stimulatory B-cell-T-cell interactions are critical for T-cell help recruited by glycoconjugate vaccines. Infect Immun. 1999 Dec; 67(12):6375-84. PMID: 10569753.
      Citations: 33     Fields:    Translation:AnimalsCellsPHPublic Health
    170. Wekerle T, Sayegh MH, Ito H, Hill J, Chandraker A, Pearson DA, Swenson KG, Zhao G, Sykes M. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation. 1999 Nov 15; 68(9):1348-55. PMID: 10573075.
      Citations: 25     Fields:    Translation:Animals
    171. Chandraker A. Diagnostic techniques in the work-up of renal allograft dysfunction--an update. Curr Opin Nephrol Hypertens. 1999 Nov; 8(6):723-8. PMID: 10630820.
      Citations: 5     Fields:    Translation:HumansAnimals
    172. Magee CC, Azuma H, Knoflach A, Denton MD, Chandraker A, Iyer S, Buelow R, Sayegh M. In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide. J Am Soc Nephrol. 1999 Sep; 10(9):1997-2005. PMID: 10477153.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    173. Mackinnon FG, Ho Y, Blake MS, Michon F, Chandraker A, Sayegh MH, Wetzler LM. The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin. J Infect Dis. 1999 Sep; 180(3):755-61. PMID: 10438364.
      Citations: 22     Fields:    Translation:AnimalsCells
    174. Chandraker A. Ischemia-reperfusion injury in experimental models of organ transplantation. Transplant Proc. 1999 Aug; 31(5):2073. PMID: 10455973.
      Citations:    Fields:    Translation:AnimalsCells
    175. Onodera K, Chandraker A, Volk HD, Ritter T, Lehmann M, Kato H, Sayegh MH, Kupiec-Weglinski JW. Distinct tolerance pathways in sensitized allograft recipients after selective blockade of activation signal 1 or signal 2. Transplantation. 1999 Jul 27; 68(2):288-93. PMID: 10440403.
      Citations: 5     Fields:    Translation:AnimalsCells
    176. Saborio DV, Chowdhury NC, Jin MX, Chandraker A, Sayegh MH, Oluwole SF. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Cell Transplant. 1999 Jul-Aug; 8(4):375-81. PMID: 10478717.
      Citations: 1     Fields:    Translation:AnimalsCells
    177. Wekerle T, Sayegh MH, Chandraker A, Swenson KG, Zhao Y, Sykes M. Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade. Transplant Proc. 1999 Feb-Mar; 31(1-2):680. PMID: 10083292.
      Citations: 6     Fields:    Translation:AnimalsCells
    178. Onodera K, Chandraker A, Kato H, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Distinct tolerance pathways in sensitized rat recipients after blockade of activation signal 1 and signal 2. Transplant Proc. 1999 Feb-Mar; 31(1-2):876-7. PMID: 10083384.
      Citations:    Fields:    Translation:AnimalsCellsPHPublic Health
    179. Chowdhury NC, Saborio DV, Garrovillo M, Chandraker A, Magee CC, Waaga AM, Sayegh MH, Jin MX, Oluwole SF. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Transplantation. 1998 Oct 27; 66(8):1059-66. PMID: 9808492.
      Citations: 2     Fields:    Translation:AnimalsCells
    180. Takada M, Nadeau KC, Hancock WW, Mackenzie HS, Shaw GD, Waaga AM, Chandraker A, Sayegh MH, Tilney NL. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation. 1998 Jun 27; 65(12):1533-42. PMID: 9665067.
      Citations: 53     Fields:    Translation:AnimalsCells
    181. Wekerle T, Sayegh MH, Hill J, Zhao Y, Chandraker A, Swenson KG, Zhao G, Sykes M. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med. 1998 Jun 15; 187(12):2037-44. PMID: 9625763.
      Citations: 78     Fields:    Translation:AnimalsCells
    182. Chandraker A, Azuma H, Nadeau K, Carpenter CB, Tilney NL, Hancock WW, Sayegh MH. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest. 1998 Jun 01; 101(11):2309-18. PMID: 9616202.
      Citations: 16     Fields:    Translation:AnimalsCells
    183. Kato H, Onodera K, Chandraker A, Volk HD, Sayegh MH, Kupiec-Weglinski JW. CD4-targeted therapy and CD28-B7 costimulatory blockage may independently induce tolerance in sensitized allograft recipients. Transplant Proc. 1998 Jun; 30(4):1063-4. PMID: 9636430.
      Citations: 1     Fields:    Translation:Animals
    184. Schaub M, Stadlbauer TH, Chandraker A, Vella JP, Turka LA, Sayegh MH. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen. J Am Soc Nephrol. 1998 May; 9(5):891-8. PMID: 9596088.
      Citations: 4     Fields:    Translation:AnimalsCells
    185. Waaga AM, Chandraker A, Spadafora-Ferreira M, Iyengar AR, Khoury SJ, Carpenter CB, Sayegh MH. Mechanisms of indirect allorecognition: characterization of MHC class II allopeptide-specific T helper cell clones from animals undergoing acute allograft rejection. Transplantation. 1998 Apr 15; 65(7):876-83. PMID: 9565089.
      Citations: 8     Fields:    Translation:AnimalsCells
    186. Onodera K, Chandraker A, Volk HD, Lehmann M, Korom S, Stadlbauer TH, Kato K, Kasai S, Sayegh MH, Kupiec-Weglinski JW. Role of regulatory T cells in the "infectious" tolerance pathway in transplant recipients. Transplant Proc. 1998 Feb; 30(1):13-5. PMID: 9474942.
      Citations:    Fields:    Translation:AnimalsCells
    187. Onodera K, Chandraker A, Korom S, Stadlbauer TH, Kato K, Kasai S, Sayegh MH, Kupiec-Weglinski JW. Agonistic and antagonistic interactions between CTLA4Ig and donor alloantigens in sensitized rat recipients of cardiac allografts. Transplant Proc. 1998 Feb; 30(1):16-8. PMID: 9474943.
      Citations:    Fields:    Translation:HumansAnimalsPHPublic Health
    188. Chandraker A, Takada M, Nadeau KC, Peach R, Tilney NL, Sayegh MH. CD28-b7 blockade in organ dysfunction secondary to cold ischemia/reperfusion injury. Kidney Int. 1997 Dec; 52(6):1678-84. PMID: 9407517.
      Citations: 17     Fields:    Translation:Animals
    189. Gallon L, Chandraker A, Issazadeh S, Peach R, Linsley PS, Turka LA, Sayegh MH, Khoury SJ. Differential effects of B7-1 blockade in the rat experimental autoimmune encephalomyelitis model. J Immunol. 1997 Nov 01; 159(9):4212-6. PMID: 9379015.
      Citations: 7     Fields:    Translation:AnimalsCells
    190. Takada M, Chandraker A, Nadeau KC, Sayegh MH, Tilney NL. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest. 1997 Sep 01; 100(5):1199-203. PMID: 9276737.
      Citations: 40     Fields:    Translation:Animals
    191. Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses. J Immunol. 1997 Aug 15; 159(4):1711-7. PMID: 9257832.
      Citations: 8     Fields:    Translation:HumansAnimals
    192. Korom S, De Meester I, Stadlbauer TH, Chandraker A, Schaub M, Sayegh MH, Belyaev A, Haemers A, Scharp? S, Kupiec-Weglinski JW. Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients. Transplantation. 1997 May 27; 63(10):1495-500. PMID: 9175816.
      Citations: 8     Fields:    Translation:AnimalsCells
    193. Chandraker A, Russell ME, Glysing-Jensen T, Willett TA, Sayegh MH. T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen. Transplantation. 1997 Apr 27; 63(8):1053-8. PMID: 9133464.
      Citations: 6     Fields:    Translation:Animals
    194. Akalin E, Chandraker A, Sayegh M, Turka LA. Role of the CD28:B7 costimulatory interaction in alloimmune responses. Kidney Int Suppl. 1997 Mar; 58:S8-10. PMID: 9067935.
      Citations: 2     Fields:    Translation:Humans
    195. Nadeau K, Azuma H, Chandraker A, Sayegh MH, Tilney NL. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection. Transplant Proc. 1997 Feb-Mar; 29(1-2):1038. PMID: 9123187.
      Citations:    Fields:    Translation:AnimalsCells
    196. Onodera K, Hancock WW, Graser E, Volk HD, Lehmann M, Chandraker A, Sayegh MH, Kupiec-Weglinski JW. Th2-type cytokines in the "infectious" tolerance pathway. Transplant Proc. 1997 Feb-Mar; 29(1-2):1290-1. PMID: 9123311.
      Citations: 3     Fields:    Translation:AnimalsCells
    197. Knoflach A, Chandraker A, Sayegh MH. Chronic rejection from bedside to bench: role of T cells. Ann Transplant. 1997; 2(2):53-60. PMID: 9869853.
      Citations:    Fields:    Translation:HumansAnimalsCells
    198. Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH. CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo. Transplantation. 1996 Dec 27; 62(12):1942-5. PMID: 8990393.
      Citations: 12     Fields:    Translation:AnimalsCells
    199. Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A. 1996 Oct 29; 93(22):12439-44. PMID: 8901600.
      Citations: 37     Fields:    Translation:AnimalsCells
    200. Khoury SJ, Gallon L, Verburg RR, Chandraker A, Peach R, Linsley PS, Turka LA, Hancock WW, Sayegh MH. Ex vivo treatment of antigen-presenting cells with CTLA4Ig and encephalitogenic peptide prevents experimental autoimmune encephalomyelitis in the Lewis rat. J Immunol. 1996 Oct 15; 157(8):3700-5. PMID: 8871673.
      Citations: 7     Fields:    Translation:AnimalsCells
    201. Khoury SJ, Akalin E, Chandraker A, Turka LA, Linsley PS, Sayegh MH, Hancock WW. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol. 1995 Nov 15; 155(10):4521-4. PMID: 7594447.
      Citations: 42     Fields:    Translation:AnimalsCells
    202. Renwick DS, Chandraker A, Bannister P. Missed neuroleptic malignant syndrome. BMJ. 1992 Mar 28; 304(6830):831-2. PMID: 1392715.
      Citations: 4     Fields:    Translation:Humans
    Chandraker's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (661)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _